NeuroSense Therapeutics Ltd. (NRSN) - Total pendapatan perusahaan
NeuroSense Therapeutics (NRSN) develops therapies for ALS and Alzheimer's disease while strictly adhering to biohazardous waste disposal standards. The company's commercial sales volume visualizes actual cash flow without speculation, with the indicator reaching 0.00. High business scalability is driven by patents that enable the global distribution of innovative drugs with minimal production costs.
Rincian analitis perusahaan NeuroSense Therapeutics Ltd (NRSN)
- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang marang Modal NeuroSense Therapeutics|NRSN - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal NeuroSense Therapeutics, Ltd.|NRSN - Gunggung utang perusahaan|Utang marang modal buku NeuroSense Therapeutics Ltd.|NRSN - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan NeuroSense Therapeutics|Likuiditas darurat neurosense-tx.com
- rincian asil keuangan lan kelipatan valuasi:
NRSN - Bathi resik perusahaan|Penghasilan resik sing dikarepake NeuroSense Therapeutics|NRSN - Pangali P/E|Pangali Forward P/E NeuroSense Therapeutics, Ltd.|NRSN - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan NeuroSense Therapeutics Ltd.|NRSN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan NeuroSense Therapeutics|NRSN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan neurosense-tx.com|NRSN - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep NeuroSense Therapeutics
- indikator volume dodolan lan pendapatan:
Analisis umum perusahaan:neurosense-tx.com, NRSN
NeuroSense Therapeutics (NRSN) maintains a strong position in the neurodegenerative pathology sector thanks to a diversified patent portfolio. By analyzing the company's gross sales revenue, an investor can see the actual daily cash inflow from clients. This metric captures real liquidity and allows for the prompt detection of cash gaps or deviations from the financial plan. Stable growth in this indicator confirms the commercial viability of current clinical trial programs.
Pesaing wigati
Biogen Idec (BIIB) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan NBIX|RGC - Total pendapatan perusahaan|Pendapatan perusahaan Axsome Therapeutics, Inc. AXSM|ACAD: Volume dodolan perusahaan|XENE - Pendapatan perusahaan|Pendapatan reged perusahaan Viking Therapeutics Corp VKTX|SUPN: Pendapatan lan volume dodolan|Total pendapatan perusahaan catalystpharma.com (CPRX)|Dodolan perusahaan DNLI|HRMY: Pendapatan dodolan perusahaan|Dodolan perusahaan BHVN (Biohaven Pharmaceutical)|Total dodolan perusahaan AMLX|Pendapatan lan volume dodolan TRVI (Trevi Therapeutics)|Pendapatan dodolan perusahaan PRAX|Anavex Life Sciences Corp. - Pendapatan lan volume dodolan|Total pendapatan perusahaan CeriBell Inc|Prothena Corporation PLC (PRTA) - Pendapatan perusahaan|Alector - Pendapatan dodolan perusahaan|ANNX (Annexon, Inc.) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Omeros Corp.|Pendapatan perusahaan Neurogene (NGNE)|ACIU: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan VYGR (Voyager Pharma)|Neumora Corp (NMRA) - Total pendapatan perusahaan|SCLX: Dodolan perusahaan|TVGN - Pendapatan lan volume dodolan|ACOG (alphacognition.com) - Dodolan perusahaan|CGTX: Total dodolan perusahaan|IKT (Inhibikase) - Pendapatan lan volume dodolan|Cassava Pharma (SAVA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan ASRT|Dodolan perusahaan coyatherapeutics.com COYA|Pendapatan perusahaan Vistagen VTGN|Pendapatan reged perusahaan Ovid Therapeutics Inc (OVID)|ABOS - Pendapatan perusahaan|CRVO (CervoMed Corporation) - Volume dodolan perusahaan|alteritytherapeutics.com (ATHE) - Pendapatan perusahaan|Clene - Pendapatan dodolan perusahaan|Pendapatan perusahaan PepGen Inc|jupiterneurosciences.com (JUNS) - Pendapatan reged perusahaan|Pendapatan perusahaan Relmada (RLMD)|Annovis Bio Corporation - Volume dodolan perusahaan|Pendapatan perusahaan Grace Therapeutics GRCE|AIFF: Volume dodolan perusahaan|ANEW Medical, Inc. - Pendapatan lan volume dodolan|Total pendapatan perusahaan Reviva Pharmaceuticals Holdings Inc.|MTVA (metaviatx.com) - Dodolan perusahaan|NeurAxis Inc (NRXS) - Pendapatan lan volume dodolan|Pendapatan perusahaan Helius Medical Technologies, Inc.|PASG: Pendapatan dodolan perusahaan|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|NERV - Total pendapatan perusahaan|Pendapatan perusahaan Athira ATHA|ADXN: Volume dodolan perusahaan|Alzamend - Pendapatan lan volume dodolan|Total pendapatan perusahaan Cyclerion Therapeutics|PTIX (protagenic.com) - Dodolan perusahaan|Pasithea Therapeutics Corp. (KTTA) - Pendapatan lan volume dodolan|Pendapatan perusahaan Cortigent Inc|ATXI: Pendapatan dodolan perusahaan|Pendapatan perusahaan Brainstorm Cell (BCLI)|CARA - Total pendapatan perusahaan|Pendapatan perusahaan Chromocell Therapeutics Corp. CHRO|Pendapatan reged perusahaan Eliem Therapeutics, Inc. (ELYM)|Intra-Cellular - Pendapatan lan volume dodolan|Total pendapatan perusahaan Longboard|Marinus Pharmaceuticals (MRNS) - Pendapatan perusahaan|Volume dodolan perusahaan NKGN|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics Inc. (SAGE) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan SNPX|TRVN - Total pendapatan perusahaan|Vigil Neuroscience, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan WENA|CERE: Dodolan perusahaan
